HTFL
Q3 2026 EPS Estimate
$-0.13
Revenue Estimate
$57M
FY2028E EPS$0.06
FY2029E EPS$0.41

Analyst Sentiment

Wall St. Consensus
Buy
4 analysts·Low coverage
75
Score
4 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
4100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$37.00
+35.1%
Consensus
$37.00
+35.1%
Bull
$37.00
+35.1%
12-Month Target Range4 analysts
$37.00$37.00$37.00
Current $27.38Consensus
Current Price
$27.38
Upside to Consensus
$9.62

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+23.25%
EPS
FY2028
Rev+21.14%
EPS
FY2029
Rev+28.90%
EPS+644.88%

Earnings Surprises

Recent Analyst Actions

May 15, 2026Wells Fargo
Heartflow price target raised to $37 from $35 at Wells Fargo
Target:$37.00
+14.8%from $32.24
May 15, 2026Canaccord Genuity
Heartflow price target lowered to $37 from $43 at Canaccord
Target:$37.00
+14.8%from $32.24
Jan 28, 2026Wells Fargo
Heartflow initiated with an Overweight at Wells Fargo
Target:$38.00
+21.8%from $31.21
Sep 2, 2025Morgan Stanley
Heartflow initiated with an Equal Weight at Morgan Stanley
Target:$35.00
+12.3%from $31.16
Sep 2, 2025Canaccord Genuity
Heartflow initiated with a Buy at Canaccord
Target:$35.00
+12.3%from $31.16
Sep 2, 2025Stifel Nicolaus
Heartflow initiated with a Buy at Stifel
Target:$35.00
+12.3%from $31.16
Sep 2, 2025Piper Sandler
Heartflow initiated with an Overweight at Piper Sandler
Target:$38.00
+22.0%from $31.16